SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement and General Release • March 17th, 2023 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 17th, 2023 Company Industry JurisdictionThis Separation Agreement and General Release (“Agreement”) is being entered into on the date listed on the signature page hereof by and between David Cory (“Executive”) and Eiger BioPharmaceuticals, Inc. (“Company”). Executive and the Company are referred to jointly as the “Parties” or individually as a “Party.”
Second Amendment to LeaseSecond Amendment to Lease • March 17th, 2023 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 17th, 2023 Company IndustryThis Second Amendment to Lease (“Amendment”) is made and entered January 23, 2023 (the “Amendment Effective Date”) by and between McDonald Family Co. LLC (“Lessor”) and Eiger Pharmaceuticals, Inc. (“Lessee”).
VIA ELECTRONIC MAIL (davidapelian@gmail.com)Eiger BioPharmaceuticals, Inc. • March 17th, 2023 • Biological products, (no disgnostic substances) • Delaware
Company FiledMarch 17th, 2023 Industry Jurisdiction